Dermatitis due to substances taken internally

L12_INTERNALSUBSTANCEDERM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L27 Hospital discharge: ICD-9 — 693 Hospital discharge: excluded ICD-10 — L27.2 Cause of death: ICD-10 — L27 Cause of death: ICD-9 — 693 Cause of death: excluded ICD-10 — L27.2 2 out of 7 registries used, show all original rules.	2220
4. Check minimum number of events None	2220
5. Include endpoints None	2220
6. Filter based on genotype QC (FinnGen only)	2220

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF12
Parent code in ICD-10: L20-L30
Name in latin: Dermatitis e substantiis devoratis

NAME	L12_INTERNALSUBSTANCEDERM
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L27
HD_ICD_9	693
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	L272
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L27
COD_ICD_9	693
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	L272
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatitis due to substances taken internally based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2220	1426	794
Unadjusted period prevalence (%)	0.44	0.49	0.35
Median age at first event (years)	52.25	49.37	57.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3249: Matched controls
32024

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

12.7

323.0

884

916

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

31.5

323.0

449

162

XQ800

NOMESCO Finland

Prick test

10.1

323.0

757

936

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

259.9

323.0

353

L27.2

ICD-10 Finland

Dermatitis due to ingested food

1597.0

323.0

1341

L20.0

ICD-10 Finland

Besnier prurigo

+∞

323.0

912

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

597.8

323.0

1324

E0000UV

ATC

4.2

312.0

1837

7589

C01CA24

ATC

epinephrine; parenteral

9.2

308.0

703

934

D07AA02

ATC

hydrocortisone; topical

5.4

275.9

973

2335

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

244.6

233

R06AE07

ATC

cetirizine; oral

3.5

239.5

1893

9210

H02AB06

ATC

prednisolone; systemic

3.5

237.6

1753

8073

E000001

ATC

4.1

225.8

1098

3543

XQ802

NOMESCO Finland

Epicutan test

46.2

218.6

271

D07BA04

ATC

hydrocortisone and antiseptics; topical

5.3

208.8

718

1612

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

206.4

197

D07AB08

ATC

desonide; topical

6.2

198.0

587

1095

E000002

ATC

4.9

194.8

730

1789

L20

ICD-10 Finland

Atopic dermatitis

+∞

190.5

182

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.4

188.5

635

1378

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

21.6

178.7

269

133

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

5.5

174.6

571

1189

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.7

171.3

655

1618

D07AC01

ATC

betamethasone; topical

3.0

147.2

1078

4499

T78.4

ICD-10 Finland

Allergy, unspecified

6.5

142.5

399

674

D07AB02

ATC

hydrocortisone butyrate; topical

3.0

133.9

995

4145

6930B

ICD-9 Finland

Dermatitis due to substances taken internally, Due to drugs and medicines[EXANTHEMA EX USU PHARMACIS]

+∞

129.3

124

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.1

119.0

805

3109

D11AH01

ATC

tacrolimus; topical

303.6

116.3

118

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

3.9

115.5

541

1571

R06AX27

ATC

desloratadine; oral

2.5

114.6

1171

5795

D07AC13

ATC

mometasone; topical

2.8

112.3

897

3838

R03AC02

ATC

salbutamol; inhalant

2.3

110.4

1862

11812

E000003

ATC

7.0

109.7

287

436

R06AE09

ATC

levocetirizine; oral

3.1

105.3

672

2464

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

104.2

100

E000006

ATC

5.0

102.5

356

768

S01GX01

ATC

cromoglicic acid; ophthalmic

2.7

101.2

849

3705

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.9

97.8

349

774

N05BB01

ATC

hydroxyzine; systemic

4.9

97.8

345

756

D02AX

ATC

Other emollients and protectives

6.3

94.8

267

447

L50.0

ICD-10 Finland

Allergic urticaria

6.7

84.6

226

351

J01FF01

ATC

clindamycin; systemic

2.4

83.4

852

4077

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

82.5

674

2847

R03BA05

ATC

fluticasone; inhalant

2.5

81.1

786

3651

R03BA02

ATC

budesonide; inhalant

2.6

80.3

690

2996

R03DC03

ATC

montelukast; oral

2.6

75.7

640

2741

D11AX14

ATC

[U] tacrolimus; topical

+∞

74.9

6939X

ICD-9 Finland

Dermatitis due to substances taken internally, Due to unspecified substance taken internally

+∞

74.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

69.7

1197

7142

R06AX13

ATC

loratadine; oral

2.6

69.2

592

2543

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

68.6

XQ820

NOMESCO Finland

Exposure to medicinal substance

35.2

66.8

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

6.0

64.8

187

321

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

64.4

D11AH02

ATC

pimecrolimus; topical

+∞

63.4

XQ830

NOMESCO Finland

Exposure to foodstuff

41.4

62.1

XQ899

NOMESCO Finland

Other assessment of skin

64.0

60.1

R03AC03

ATC

terbutaline; inhalant

2.6

60.1

488

2020

D07AD01

ATC

clobetasol; topical

2.9

59.8

408

1519

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

12.6

59.6

109

D02AE01

ATC

carbamide; topical

3.9

56.9

250

669

R01AD09

ATC

mometasone; nasal

1.8

54.2

1377

9224

L27.9

ICD-10 Finland

Dermatitis due to unspecified substance taken internally

528.8

53.4

Z51.6

ICD-10 Finland

Desensitization to allergens

7.3

52.3

130

182

A92

ICPC

Allergy/allergic reaction NOS

3.9

51.6

226

602

505

Kela drug reimbursment

Allergy to cow's milk in infants

18.8

51.5

D11AX15

ATC

[U] pimecrolimus; topical

+∞

50.9

E000007

ATC

3.6

50.8

248

724

L50.9

ICD-10 Finland

Urticaria, unspecified

3.9

49.6

217

577

J01DB01

ATC

cefalexin; oral

1.9

49.5

2500

20568

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

7.1

48.0

121

173

D09AB01

ATC

zinc bandage without supplements; topical

11.4

47.1

H02AB07

ATC

prednisone; oral

2.5

46.9

404

1713

H02AB04

ATC

methylprednisolone; systemic

2.5

46.8

414

1780

D07CC01

ATC

betamethasone and antibiotics; topical

2.6

46.8

386

1599

J30.3

ICD-10 Finland

Other allergic rhinitis

4.1

46.5

192

485

TQW80

NOMESCO Finland

Local dermatologic skincare

7.6

46.4

112

150

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.3

45.7

481

2256

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

45.1

744

4226

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

44.9

195

515

R01AD08

ATC

fluticasone; nasal

1.9

44.3

835

4971

XQ801

NOMESCO Finland

Intracutantest

28.6

44.1

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

43.6

J01DA01

ATC

[U] cefalexin; systemic

1.7

43.1

1747

13137

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

36.7

42.9

R50.9

ICD-10 Finland

Fever, unspecified

2.1

42.4

558

2888

J01MA12

ATC

levofloxacin; systemic

2.2

41.5

469

2267

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

41.5

781

4634

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

41.4

300

1150

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

41.3

422

1948

L30.3

ICD-10 Finland

Infective dermatitis

8.7

41.2

106

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.0

40.4

566

2997

A46

ICD-10 Finland

Erysipelas

2.5

40.3

338

1409

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

40.0

298

1161

R06AX22

ATC

ebastine; oral

2.2

39.6

473

2339

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

39.6

189

541

J45

ICD-10 Finland

Asthma

2.5

38.7

325

1354

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

38.6

248

880

D07BC01

ATC

betamethasone and antiseptics; topical

2.6

37.8

291

1153

S87

ICPC

Dermatitis/atopic eczema

4.9

37.2

125

257

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

32.0

36.4

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.5

35.0

144

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

34.8

605

3461

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.9

34.7

150

395

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

94.7

34.5

J01MA02

ATC

ciprofloxacin; systemic

1.7

34.0

907

5945

R01AD12

ATC

fluticasone furoate; nasal

1.7

34.0

944

6261

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

119.5

33.5

E000004

ATC

5.6

33.3

100

181

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

33.3

603

3495

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.1

33.1

189

619

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

10.9

32.6

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.5

32.0

155

449

A02BC02

ATC

pantoprazole; systemic

1.6

31.9

1539

11723

N02AX02

ATC

tramadol; systemic, rectal

1.6

31.5

963

6531

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

31.0

137

368

R06.0

ICD-10 Finland

Dyspnoea

1.8

30.7

630

3795

J45.8

ICD-10 Finland

Mixed asthma

3.9

30.4

131

344

J01FA06

ATC

roxithromycin; oral

1.6

30.2

942

6409

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

58.1

29.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

29.8

456

2476

J01FA10

ATC

azithromycin; systemic

1.5

29.3

1978

16146

L04AX01

ATC

azathioprine; systemic

3.1

29.1

168

555

6930A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to drugs and medicines[ECZEMA EX USU PHARMACIS]

+∞

29.0

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

28.6

676

4241

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.3

28.6

275

1223

R96

ICPC

Asthma

2.3

28.0

273

1222

J46

ICD-10 Finland

Status asthmaticus

4.4

27.7

102

232

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

27.5

551

3278

WQ000

NOMESCO Finland

Hyposensibilisation

7.4

27.5

L50.8

ICD-10 Finland

Other urticaria

5.2

27.4

165

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

27.2

313

1513

J01FA09

ATC

clarithromycin; systemic

1.6

27.1

946

6588

J05AB01

ATC

aciclovir; systemic

1.8

26.8

553

3318

D07XC01

ATC

betamethasone, combinations; topical

2.3

26.8

263

1180

J01MA14

ATC

moxifloxacin; systemic

2.5

26.6

214

867

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

26.6

1579

12401

L26

ICD-10 Finland

Exfoliative dermatitis

269.2

26.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

26.4

492

2859

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

26.0

267

1222

R06.2

ICD-10 Finland

Wheezing

2.7

25.9

185

698

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

25.7

619

3892

D07AB01

ATC

clobetasone; topical

4.0

25.6

105

265

C03CA01

ATC

furosemide; systemic

1.7

25.3

546

3321

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

25.3

897

6248

D07AC14

ATC

methylprednisolone aceponate; topical

3.2

24.5

131

410

N03AX16

ATC

pregabalin; oral

1.7

24.2

520

3153

WZC30

NOMESCO Finland

Teaching

2.0

24.2

329

1702

Z3231

NOMESCO Finland

Registered nurse

1.6

23.9

838

5805

R01AC01

ATC

cromoglicic acid; nasal

2.9

23.9

148

512

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

23.8

1045

7627

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

23.7

567

3547

H02AB02

ATC

dexamethasone; systemic

2.2

23.3

252

1183

J02AC01

ATC

fluconazole; systemic

1.5

23.2

982

7100

J01AA02

ATC

doxycycline; systemic

1.5

23.2

1826

15018

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

23.2

187

760

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

23.2

363

1978

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

23.1

445

2603

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

23.1

682

4521

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

22.9

536

3328

P01BA02

ATC

hydroxychloroquine; oral

2.3

22.6

219

977

XQ848

NOMESCO Finland

Dermatological photography

4.7

22.5

163

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.1

22.4

127

413

J01FA01

ATC

erythromycin; systemic

1.8

22.4

415

2397

J05AB11

ATC

valaciclovir; oral

1.9

22.2

331

1770

ZX120

NOMESCO Finland

Intravenous

2.1

22.0

265

1304

R02

ICPC

Shortness of breath/dyspnoea

1.9

21.8

336

1819

D07XB05

ATC

dexamethasone, combinations; topical

4.3

21.5

190

UJF32

NOMESCO Finland

Coloscopy

1.7

21.4

545

3461

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

21.2

473

2891

L50.3

ICD-10 Finland

Dermatographic urticaria

5.2

20.7

126

X57

ICD-10 Finland

Unspecified privation

4.2

20.4

190

N03AX12

ATC

gabapentin; oral

1.9

20.3

337

1873

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

20.3

475

2942

JN4AD

NOMESCO Finland

Body CT examination

2.5

20.3

162

655

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

20.2

177

751

A02BC05

ATC

esomeprazole; systemic

1.5

20.2

880

6364

L30.8

ICD-10 Finland

Other specified dermatitis

5.7

20.1

102

S01GX02

ATC

levocabastine; ophthalmic

2.3

19.9

183

795

L30.0

ICD-10 Finland

Nummular dermatitis

4.2

19.8

177

N02AA05

ATC

oxycodone; systemic

1.9

19.8

293

1564

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.0

19.7

119

407

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

19.6

204

939

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.9

19.4

282

1493

ZX108

NOMESCO Finland

Inhalation

6.2

19.3

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

11.6

19.0

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

19.0

202

938

R05

ICD-10 Finland

Cough

1.6

19.0

538

3506

R03BA01

ATC

beclometasone; inhalant

1.9

19.0

316

1755

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

18.9

181

803

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

18.8

697

4854

L27.8

ICD-10 Finland

Dermatitis due to other substances taken internally

+∞

18.7

N02BE01

ATC

paracetamol; systemic, rectal

1.4

18.6

2269

19821

R06AX26

ATC

fexofenadine; oral

2.3

18.5

173

757

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

18.0

248

1287

P01AB01

ATC

metronidazole; oral, rectal

1.5

18.0

918

6832

M79.6

ICD-10 Finland

Pain in limb

1.5

17.7

867

6388

M04AA01

ATC

allopurinol; systemic

2.0

17.7

231

1174

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

17.7

202

969

395

Kela drug reimbursment

Dupilumab

+∞

17.6

D11AH05

ATC

dupilumab; topical

+∞

17.6

L04AD01

ATC

ciclosporin; systemic

3.7

17.5

209

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

36.4

17.5

A02BC03

ATC

lansoprazole; oral

1.6

17.4

574

3881

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

17.4

960

7246

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

17.2

244

1280

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

17.1

804

5874

AA1AD

NOMESCO Finland

CT of head and brain

1.6

17.0

475

3076

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

16.9

231

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

25.3

16.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

16.7

215

1085

JN4BD

NOMESCO Finland

Extensive body CT

2.0

16.6

228

1182

ZXE00

NOMESCO Finland

One hour or less

1.4

16.5

1089

8471

J30.19

ICD-10 Finland

Pollen allergy UNS

2.6

16.5

125

492

N03AF01

ATC

carbamazepine; oral, rectal

2.6

16.5

121

467

134

Kela drug reimbursment

General erythroderma

19.8

16.3

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

16.3

181

862

R11

ICD-10 Finland

Nausea and vomiting

1.9

16.1

258

1414

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

16.1

344

2067

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.1

1620

13519

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

16.0

162

737

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.5

16.0

126

507

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

16.0

294

1686

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

8.7

16.0

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

24.2

15.9

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.8

15.9

101

357

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

15.8

184

893

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

15.7

417

2667

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.6

720

5223

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

15.6

988

7613

N05BA04

ATC

oxazepam; oral

1.5

15.4

567

3916

XW000

NOMESCO Finland

Bone marrow biopsy

2.6

15.1

113

442

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

15.0

122

499

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

15.0

317

1899

N03AG01

ATC

valproic acid; systemic, rectal

2.1

14.9

175

853

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

14.9

14.7

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

14.7

252

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

14.6

162

769

S01GX08

ATC

ketotifen; ophthalmic

2.5

14.6

116

467

S01AD03

ATC

aciclovir; ophthalmic

2.9

14.6

314

L51.0

ICD-10 Finland

Nonbullous erythema multiforme

20.8

14.5

506

Kela drug reimbursment

Allergy to cow's milk and hypersensibility to conventional formula in infants

20.8

14.5

A04AA02

ATC

granisetron; systemic, transdermal

2.3

14.5

131

568

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

14.4

119

493

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.9

14.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

14.3

201

1051

L04AA01

ATC

[U] ciclosporin; systemic

4.3

14.3

124

R03BA08

ATC

ciclesonide; inhalant

2.0

14.3

184

929

WW200

NOMESCO Finland

Immunization

2.9

14.3

313

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.8

14.3

329

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

14.3

355

2224

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

14.2

874

6677

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

14.2

215

1153

S01GX09

ATC

olopatadine; ophthalmic

2.9

14.1

303

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

11.2

14.1

L04AA06

ATC

mycophenolic acid; systemic

3.6

14.0

176

S76

ICPC

Skin infection other

2.3

14.0

133

591

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

13.8

229

1272

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

13.8

480

3270

A03FA02

ATC

cisapride; oral, rectal

2.0

13.7

186

960

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

13.7

223

1230

E930A

ICD-9 Finland

Antibiotics[PENISILLIINIT]

52.8

13.7

A02BA02

ATC

ranitidine; systemic

1.6

13.7

372

2387

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

13.7

169

843

SPAT1263

SPAT

Sampling

1.3

13.6

1247

10157

M25.5

ICD-10 Finland

Pain in joint

1.4

13.5

673

4937

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

74.3

13.5

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.4

13.4

115

484

R03BC01

ATC

cromoglicic acid; inhalant

3.8

13.3

143

N05CF01

ATC

zopiclone; oral

1.4

13.2

624

4530

WX002

NOMESCO Finland

Sedation and analgesia

1.5

13.1

423

2829

S29

ICPC

Skin symptom/complaint other

1.5

13.1

433

2914

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

13.1

217

1203

153

Kela drug reimbursment

Lenalidomid

9.6

13.1

L04AX04

ATC

lenalidomide; oral

9.6

13.1

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.5

13.1

104

423

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.7

13.0

332

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.9

13.0

258

A02BC01

ATC

omeprazole; systemic

1.4

13.0

603

4364

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

12.9

225

1268

N05BA01

ATC

diazepam; systemic, rectal

1.7

12.8

295

1812

T78.3

ICD-10 Finland

Angioneurotic oedema

4.3

12.7

106

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

12.7

180

945

R01AD11

ATC

triamcinolone; nasal

1.8

12.7

205

1129

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

12.6

161

814

R60.0

ICD-10 Finland

Localized oedema

1.8

12.6

215

1204

A03

ICPC

Fever

1.4

12.6

624

4566

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

12.6

169

871

R53

ICD-10 Finland

Malaise and fatigue

1.5

12.5

497

3481

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

12.5

256

1518

S18

ICPC

Laceration/cut

1.3

12.5

992

7872

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

12.5

454

3118

A04AA01

ATC

ondansetron; systemic, rectal

1.9

12.5

172

895

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

8.1

12.4

L04AB04

ATC

adalimumab; parenteral

3.2

12.3

206

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

12.3

171

893

R03AC12

ATC

salmeterol; inhalant

2.4

12.2

104

436

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.5

12.2

155

W84

ICD-10 Finland

Unspecified threat to breathing

8.9

12.1

D05BB02

ATC

acitretin; oral

3.6

12.1

146

R51.80

ICD-10 Finland

Headache

1.5

12.0

439

3016

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

12.0

306

1928

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.9

12.0

SPAT1153

SPAT

Removal of sutures

1.4

12.0

677

5073

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

11.9

381

S97

ICPC

Chronic ulcer skin

2.4

11.9

102

429

A06AD11

ATC

lactulose; oral

1.6

11.9

283

1750

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.9

1075

8685

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

11.8

668

5001

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

11.8

105

452

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.9

11.8

234

S21

ICPC

Skin texture symptom/complaint

1.6

11.8

302

1907

R01AD01

ATC

beclometasone; nasal

1.6

11.7

315

2014

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

11.7

1223

10089

A07AA02

ATC

nystatin; oral

2.1

11.6

136

664

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

9.5

11.6

S88

ICPC

Dermatitis contact/allergic

2.8

11.6

254

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

11.5

189

SPAT1312

SPAT

General health counselling

1.3

11.5

1112

9064

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

11.5

202

1145

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

11.4

J20

ICD-10 Finland

Acute bronchitis

1.7

11.4

222

1298

UDC00

NOMESCO Finland

Ear microscopy

1.8

11.4

215

1245

D01AC02

ATC

miconazole; topical

2.0

11.4

151

775

G47.3

ICD-10 Finland

Sleep apnoea

1.5

11.2

356

2368

H02AB09

ATC

hydrocortisone; systemic

2.4

11.2

389

Z88.1

ICD-10 Finland

Personal history of allergy to other antibiotic agents

34.6

11.2

ZXD05

NOMESCO Finland

Urgent procedure

1.4

11.1

757

5848

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.1

11.0

103

X58

ICD-10 Finland

Exposure to other specified factors

1.5

11.0

380

2580

M79.1

ICD-10 Finland

Myalgia

1.6

11.0

304

1959

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.6

11.0

310

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

10.9

200

1146

L04AA13

ATC

leflunomide; oral

2.9

10.9

219

J01XX08

ATC

linezolid; systemic

9.1

10.9

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.4

10.8

388

N06AX11

ATC

mirtazapine; oral

1.4

10.8

686

5233

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

10.8

522

3795

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

10.8

974

7847

SPAT1260

SPAT

Consultation of another employee

1.5

10.7

461

3272

SPAT1301

SPAT

No procedures

1.3

10.7

876

6951

A01AB09

ATC

miconazole; local oral

1.7

10.7

209

1221

M54.5

ICD-10 Finland

Low back pain

1.4

10.7

759

5887

R55

ICD-10 Finland

Syncope and collapse

1.7

10.7

230

1384

L29.9

ICD-10 Finland

Pruritus, unspecified

3.5

10.7

136

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

21.2

10.6

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.4

10.6

142

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.3

10.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

10.5

343

2301

R06AX11

ATC

astemizole; oral

2.4

10.4

364

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

10.4

453

3222

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

10.4

211

1249

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

10.4

567

4210

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

10.4

137

703

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

108.7

10.4

N03AX09

ATC

lamotrigine; oral

2.0

10.3

135

690

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.1

10.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

10.3

100

451

J01XC01

ATC

fusidic acid; systemic

4.3

10.3

ZX112

NOMESCO Finland

Subcutaneous

2.8

10.3

233

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

32.1

10.2

D07CB01

ATC

triamcinolone and antibiotics; topical

3.2

10.2

162

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.5

10.2

307

C07AB07

ATC

bisoprolol; oral

1.3

10.2

839

6656

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

10.2

125

623

Z00.0

ICD-10 Finland

General medical examination

1.4

10.2

523

3839

A07EA06

ATC

budesonide; oral, local oral

2.3

10.1

407

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

10.1

127

640

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

10.1

409

R01AD05

ATC

budesonide; nasal

1.8

10.1

175

988

A28

ICPC

Limited function/disability NOS

1.6

10.1

261

1653

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

10.1

117

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

10.0

844

6719

B01AB05

ATC

enoxaparin; parenteral

1.4

10.0

560

4175

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.6

9.9

Z51.5

ICD-10 Finland

Palliative care

2.1

9.9

107

506

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

9.9

275

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

9.9

313

2081

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

9.9

123

618

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.4

9.9

319

WW500

NOMESCO Finland

Blood transfusion

2.2

9.9

441

B02.9

ICD-10 Finland

Zoster without complication

2.0

9.8

116

570

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

9.8

192

1126

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

9.8

156

856

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

9.8

141

749

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

9.8

210

1263

R03CC02

ATC

salbutamol; systemic

1.4

9.8

431

3073

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

9.8

360

2474

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

12.0

9.7

SPAT1325

SPAT

Vaccination

1.3

9.7

1023

8394

C91.4

ICD-10 Finland

Hairy-cell leukaemia

54.3

9.6

UKC02

NOMESCO Finland

Cystoscopy

1.6

9.6

271

1757

SPAT1229

SPAT

Assessment of need for aid

1.9

9.5

148

804

R42

ICD-10 Finland

Dizziness and giddiness

1.4

9.5

437

3139

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.1

9.5

161

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

9.4

247

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

14.8

9.4

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

9.4

301

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.4

952

7764

L27

ICD-10 Finland

Dermatitis due to substances taken internally

+∞

9.3

XQ817

NOMESCO Finland

+∞

9.3

E930W

ICD-9 Finland

Antibiotics[MUUT MÄÄRITELLYT ANTIBIOOTIT]

+∞

9.3

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.7

9.3

226

A07EB01

ATC

cromoglicic acid; oral

21.4

9.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.5

9.2

121

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

9.2

164

934

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.4

9.2

317

L71.9

ICD-10 Finland

Rosacea, unspecified

3.2

9.2

148

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

9.2

132

702

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

9.2

316

2142

S01GX04

ATC

nedocromil; ophthalmic

3.3

9.1

133

C90.0

ICD-10 Finland

Multiple myeloma

5.0

9.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

9.1

414

2970

J01CA04

ATC

amoxicillin; systemic

1.3

9.0

2614

24240

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.7

9.0

103

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.2

9.0

145

B35.3

ICD-10 Finland

Tinea pedis

2.2

9.0

398

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.0

936

7652

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

9.9

8.9

EMB30

NOMESCO Finland

Adenotomy

1.6

8.9

250

1615

K30

ICD-10 Finland

Functional dyspepsia

1.6

8.9

213

1324

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

8.9

367

2581

R03AC13

ATC

formoterol; inhalant

2.1

8.9

100

484

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

8.9

203

1245

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

8.9

272

1794

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

8.9

394

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

23.7

8.8

J01FA15

ATC

telithromycin; oral

1.7

8.8

196

1193

N06AX16

ATC

venlafaxine; oral

1.5

8.8

309

2104

M01AE02

ATC

naproxen; oral, rectal

1.2

8.8

1652

14498

WIX00

NOMESCO Finland

Allergy cleanup guidance

12.4

8.8

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.0

8.8

159

R06AX18

ATC

acrivastine; oral

2.6

8.8

227

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.8

664

5189

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

8.8

353

2472

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

8.7

297

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

8.7

180

1076

N06AX21

ATC

duloxetine; oral

1.6

8.6

215

1349

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

8.6

323

R07.3

ICD-10 Finland

Other chest pain

1.7

8.6

182

1093

L03AA02

ATC

filgrastim; parenteral

2.5

8.6

249

SPAT1255

SPAT

Intravenous administration of medicine

1.8

8.5

134

732

L28.0

ICD-10 Finland

Lichen simplex chronicus

11.4

8.5

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

11.4

8.5

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

11.4

8.5

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

8.5

203

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

8.5

194

1192

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.3

8.4

125

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

8.4

197

L21.0

ICD-10 Finland

Seborrhoea capitis

6.8

8.4

N03AF02

ATC

oxcarbazepine; oral

2.1

8.4

465

SPAT1240

SPAT

Therapeutic discussion

1.4

8.4

355

2511

49300

ICD-8 Finland

Asthma, bronchiale

2.9

8.3

163

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

5.1

8.3

J02AC02

ATC

itraconazole; systemic

1.5

8.3

338

2371

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

8.3

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.0

8.3

149

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

8.2

235

1526

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

8.2

175

1052

J04.0

ICD-10 Finland

Acute laryngitis

1.7

8.2

151

872

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

8.2

432

A07EC02

ATC

mesalazine; oral, rectal

1.8

8.2

127

694

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.1

8.1

140

E0001A1

ATC

2.2

8.1

346

J01DA08

ATC

[U] cefaclor; oral

1.4

8.1

424

3119

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

8.1

190

1175

B00.10

ICD-10 Finland

Herpes simplex facialis

4.9

8.1

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

8.0

393

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

8.0

167

999

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

8.0

150

871

TGC00

NOMESCO Finland

Bronchial lavation

2.7

8.0

185

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

8.0

110

576

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

8.0

211

1344

J01EA01

ATC

trimethoprim; systemic

1.3

7.9

577

4474

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

7.9

136

768

H01.0

ICD-10 Finland

Blepharitis

1.8

7.9

130

724

C08CA01

ATC

amlodipine; oral

1.3

7.9

562

4344

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

7.8

103

531

S06

ICPC

Rash localized

1.7

7.8

144

832

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.9

7.8

154

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.9

7.8

116

623

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

7.7

149

873

R03DA04

ATC

theophylline; systemic, rectal

2.0

7.7

486

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

7.7

440

3284

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.0

7.6

141

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

7.6

142

823

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

7.6

140

809

SPAT1254

SPAT

Administration of medicine

1.3

7.6

512

3927

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

7.6

113

612

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

7.5

115

ULC02

NOMESCO Finland

Hysteroscopy

1.9

7.5

504

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

7.5

454

S02

ICPC

Pruritus

1.9

7.5

102

535

B07.9

ICD-10 Finland

Verruca simplex

1.9

7.5

102

535

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

6.1

7.4

N03AE01

ATC

clonazepam; systemic

1.9

7.4

109

584

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

7.4

933

7774

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

7.4

223

1470

P03

ICPC

Feeling depressed

1.4

7.4

339

2433

J01DA06

ATC

[U] cefuroxime; systemic

1.4

7.4

297

2080

R4110

NOMESCO Finland

Physiotherapy

1.3

7.4

600

4723

D06BB03

ATC

aciclovir; topical

1.9

7.4

514

Z3226

NOMESCO Finland

Physiotherapist

1.4

7.4

463

3508

E931A

ICD-9 Finland

Other anti-infectives[SULFONAMIDIT]

79.1

7.4

B01AB10

ATC

tinzaparin; parenteral

1.8

7.4

126

713

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

7.3

203

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.4

7.3

239

212

Kela drug reimbursment

Gout

3.2

7.3

112

J01DC02

ATC

cefuroxime; systemic

1.7

7.3

136

790

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.6

7.3

174

1082

WX110

NOMESCO Finland

Local anesthesy

1.2

7.3

2014

18259

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.5

7.3

215

N06AA09

ATC

amitriptyline; systemic

1.6

7.3

166

1022

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

7.3

249

1687

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

7.3

N03AX14

ATC

levetiracetam; systemic

2.1

7.2

380

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

7.2

177

1109

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

7.2

164

1006

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

10.7

7.2

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

7.2

123

696

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.6

7.2

L50

ICD-10 Finland

Urticaria

2.5

7.2

206

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.2

1096

9324

1CX01

NOMESCO Finland

9.2

7.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

7.2

335

2413

N05AH04

ATC

quetiapine; oral

1.4

7.2

413

3086

G44.2

ICD-10 Finland

Tension-type headache

1.4

7.2

297

2094

J47

ICD-10 Finland

Bronchiectasis

3.1

7.2

114

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

7.1

907

7559

L93.0

ICD-10 Finland

Discoid lupus erythematosus

7.2

7.1

L51.1

ICD-10 Finland

Bullous erythema multiforme

19.8

7.1

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

7.1

239

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

7.1

180

1140

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

7.1

496

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.0

474

3629

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.0

349

2541

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.7

7.0

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

7.0

190

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

7.0

122

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.0

7.0

122

A01AB10

ATC

natamycin; local oral

2.0

7.0

412

M79.7

ICD-10 Finland

Fibromyalgia

2.1

6.9

352

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.5

6.9

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

6.9

157

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

6.9

167

1042

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.6

6.9

184

C09CA06

ATC

candesartan; oral

1.4

6.9

380

2821

H57.1

ICD-10 Finland

Ocular pain

2.0

6.8

408

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.2

6.8

289

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

6.8

114

641

K50.8

ICD-10 Finland

Other Crohn disease

2.6

6.8

176

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

6.8

231

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

6.8

119

H25.8

ICD-10 Finland

Other senile cataract

1.6

6.8

153

940

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

6.8

198

1297

N06AB10

ATC

escitalopram; oral

1.3

6.7

501

3892

329

Kela drug reimbursment

Lenalidomide

8.1

6.7

C07AA05

ATC

propranolol; systemic

1.3

6.7

439

3346

L01XE03

ATC

[U] erlotinib; oral

39.4

6.7

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

6.7

129

758

B01AC04

ATC

clopidogrel; oral

1.5

6.7

212

1412

R13

ICD-10 Finland

Dysphagia

1.8

6.7

107

592

M03BX02

ATC

tizanidine; oral

1.2

6.7

1290

11233

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

6.7

515

N48.1

ICD-10 Finland

Balanoposthitis

2.2

6.6

267

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.6

6.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

6.6

105

581

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.5

6.6

201

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.6

1277

11113

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

6.6

451

3459

L28.1

ICD-10 Finland

Prurigo nodularis

22.2

6.6

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

6.6

437

R52.2

ICD-10 Finland

Other chronic pain

2.1

6.6

313

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

6.6

231

1572

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.6

138

830

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

6.6

190

1242

Z31.5

ICD-10 Finland

Genetic counselling

1.7

6.6

141

854

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.5

6.5

186

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

6.5

322

2342

L30

ICD-10 Finland

Other dermatitis

2.6

6.5

178

XQ845

NOMESCO Finland

Dermatoscopy

3.7

6.5

L04AB01

ATC

etanercept; parenteral

2.7

6.5

145

J01CF05

ATC

flucloxacillin; systemic

2.0

6.5

377

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

6.5

162

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

6.5

171

1092

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.6

6.5

155

964

UJK02

NOMESCO Finland

ERCP

2.6

6.5

169

EMB10

NOMESCO Finland

Tonsillectomy

1.5

6.5

192

1259

L13

ICPC

Hip symptom/complaint

1.4

6.5

284

2022

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.2

6.5

296

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.5

181

1173

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

9.9

6.5

120

Kela drug reimbursment

Hypogammaglobulinaemia

9.9

6.5

D05AX52

ATC

calcipotriol, combinations; topical

1.9

6.4

479

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

6.4

440

E930F

ICD-9 Finland

Antibiotics[KEFALOSPORIINIT]

69.0

6.4

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

69.0

6.4

L28

ICPC

Limited function/disability (L)

1.4

6.4

273

1938

M01AH02

ATC

rofecoxib; oral

1.5

6.4

207

1390

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

6.4

211

1422

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

6.4

L04AC05

ATC

ustekinumab; parenteral

5.6

6.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

6.4

129

R06AE08

ATC

3.5

6.4

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

6.3

117

680

L03AA13

ATC

pegfilgrastim; parenteral

2.1

6.3

327

D05AX02

ATC

calcipotriol; topical

2.1

6.3

293

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.3

6.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

6.3

252

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.6

6.3

167

1067

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.2

6.3

R01AC02

ATC

levocabastine; nasal

2.2

6.3

287

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

6.3

346

D07XB01

ATC

flumetasone, combinations; topical

4.8

6.3

R60.1

ICD-10 Finland

Generalized oedema

4.8

6.3

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.6

6.3

161

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.6

6.3

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

6.2

174

1128

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

6.2

123

730

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.2

412

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

6.2

513

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

9.1

6.2

6938X

ICD-9 Finland

Dermatitis due to substances taken internally, Due to other specified substances taken internally

+∞

6.2

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

6.2

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

6.2

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

6.2

269

1913

L51.19

ICD-10 Finland

Other bullous erythema multiforme

26.3

6.2

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

4.5

6.2

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

3.9

6.2

A11CC03

ATC

alfacalcidol; systemic

2.4

6.2

199

S06.0

ICD-10 Finland

Concussion

1.4

6.1

286

2061

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

6.1

230

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

6.1

162

1038

S01

ICPC

Pain/tenderness of skin

1.8

6.1

539

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

6.1

140

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

6.1

345

2571

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

7.6

6.0

H05AA02

ATC

teriparatide; parenteral

7.6

6.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

6.0

299

2177

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

6.0

545

4345

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

6.0

388

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

6.0

245

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

6.0

122

NGD20

NOMESCO Finland

Reinsertion of meniscus of knee, open

12.3

6.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

6.0

474

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.4

6.0

187

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

1362

8593

2.51

94.27

10.4

5.7

e9/l

0.0

0.42

1250

7381

(3013115) Eosinophils [#/volume] in Blood

1391

8897

2.51

92.87

10.8

5.9

e9/l

0.2

5.32

1286

7767

(3001604) Monocytes [#/volume] in Blood

1355

8565

2.49

92.82

10.5

5.7

e9/l

0.6

1.04

1244

7354

(3023368) Bacteria identified in Blood by Culture

828

4231

2.53

89.92

6.0

4.1

—

(3019198) Lymphocytes [#/volume] in Blood

1375

8858

2.45

88.62

10.6

5.7

e9/l

1.9

2.0

0.25

1284

7770

(42870588) Differential panel, method unspecified - Blood

1024

5794

2.42

88.53

10.4

5.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

31.89

86.11

1.0

1.1

—

(40768443) Skin Pathology biopsy report

223

539

4.49

84.96

1.3

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1480

10004

2.44

83.30

15.5

8.8

e9/l

4.2

4.0

2.12

1364

8705

(3022096) Basophils/100 leukocytes in Blood

1223

7860

2.24

73.87

11.2

5.9

0.7

0.17

1154

7325

(3005322) IgE [Units/volume] in Serum or Plasma

300

988

3.35

73.01

1.6

1.2

u/ml

544.4

135.3

3.96

280

901

(3019069) Monocytes/100 leukocytes in Blood

1251

8153

2.22

72.46

11.5

6.1

8.5

0.09

1182

7625

(3006504) Eosinophils/100 leukocytes in Blood

1242

8109

2.21

71.11

11.3

5.8

3.1

2.8

3.88

1174

7534

(3002030) Lymphocytes/100 leukocytes in Blood

1270

8429

2.18

68.92

11.3

5.9

26.9

28.7

6.74

1202

7852

(3018010) Neutrophils/100 leukocytes in Blood

1252

8293

2.17

67.90

10.7

5.7

58.0

56.7

2.86

1185

7757

(3005719) IgG [Mass/volume] in Serum or Plasma

335

1258

2.96

64.82

4.3

2.6

g/l

10.3

10.5

0.29

310

1142

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

130

250

5.46

64.66

2.0

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1275

8700

2.09

61.52

9.5

5.8

umol/l

10.5

11.4

1.69

1217

8210

(3007853) Bacteria identified in Skin by Aerobe culture

422

1865

2.56

59.14

2.0

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1137

7513

2.05

58.98

8.9

5.7

mmol/l

1.2

2.25

1041

6790

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

166

422

4.17

58.79

2.7

1.7

g/l

0.2

0.67

156

399

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

169

440

4.07

57.94

2.7

1.6

g/l

1.1

1.2

0.77

162

414

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1216

8293

2.03

57.07

10.6

6.3

mmol/l

1.2

0.93

1019

6996

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

153

375

4.31

56.85

2.1

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

477

2273

2.40

56.54

1.5

1.3

titre

692.5

535.9

0.78

115

468

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

522

2612

2.31

55.13

2.4

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

148

365

4.27

54.52

2.1

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

325

4.46

53.95

7.5

6.2

iu/ml

323.1

458.0

0.31

(3028026) IgM [Mass/volume] in Serum or Plasma

266

978

2.95

52.98

2.3

1.8

g/l

1.2

1.3

0.57

243

896

(3017181) Myelocytes/100 leukocytes in Blood

332

1375

2.66

52.74

6.4

4.0

0.9

0.01

153

368

(3011412) CD3 cells [#/volume] in Blood

142

6.41

52.42

2.7

2.5

e9/l

1.1

0.11

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1680

13112

2.16

51.78

13.5

7.0

u/l

80.9

77.9

1.40

1605

12293

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

7.22

48.85

2.4

2.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

385

1770

2.42

48.83

6.0

4.0

u/l

254.4

248.1

0.32

360

1674

(3024561) Albumin [Mass/volume] in Serum or Plasma

1053

7113

1.91

47.76

7.7

4.6

g/l

34.8

35.8

6.73

975

6596

(3002179) Metamyelocytes/100 leukocytes in Blood

302

1251

2.64

47.70

6.2

3.8

0.6

0.02

115

273

(3032080) INR in Blood by Coagulation assay

975

6449

1.91

46.90

9.3

8.6

inr

1.2

1.50

298

1900

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

282

1145

2.68

46.30

1.9

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

658

3825

2.02

46.11

7.6

4.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

307

1311

2.56

45.45

6.6

4.1

0.1

0.02

138

343

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

116

6.47

44.12

2.3

2.4

13.5

12.5

0.19

(3042936) Bacteria identified in Isolate by Culture

449

2311

2.18

43.15

2.6

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

206

4.88

42.99

2.1

1.7

—

(3025159) Blasts/100 leukocytes in Blood

291

1253

2.52

42.19

6.6

4.1

0.8

0.1

0.51

122

295

(21494815) CD4 cells/100 lymphocytes in Specimen

132

5.93

42.04

2.0

2.3

40.7

46.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

487

2611

2.11

42.00

5.7

3.6

mmol/l

0.8

1.39

465

2443

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

175

579

3.20

41.60

2.5

1.9

ug/l

1.2

1.8

0.44

155

503

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

164

5.22

39.97

2.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

336

1587

2.32

39.52

3.1

1.9

nmol/l

339.8

376.5

2.71

314

1445

(3004789) Transferrin [Mass/volume] in Serum or Plasma

442

2347

2.10

38.79

3.0

2.4

g/l

2.3

2.4

1.52

408

2164

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

164

5.09

37.94

2.0

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

469

2566

2.05

37.88

3.0

2.3

umol/l

12.2

13.5

3.75

439

2366

(3020779) Urea [Moles/volume] in Serum or Plasma

298

1367

2.36

37.38

11.1

7.2

mmol/l

9.5

9.2

0.31

279

1306

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

414

2176

2.11

37.18

3.1

2.4

21.8

23.3

1.42

355

1857

(3013707) Erythrocyte sedimentation rate by Westergren method

1601

12880

1.87

37.18

7.0

3.9

mm/h

14.6

11.4

11.51

1504

11877

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

752

4851

1.83

36.89

2.6

2.1

u/l

159.4

233.3

1.93

708

4552

(3031040) Bacteria [#/volume] in Urine by Automated count

1484

11680

1.82

36.82

5.9

4.3

e6/l

61.5

2017.8

2.64

165

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

894

6089

1.78

36.47

4.3

3.3

ng/l

42.8

52.0

0.34

639

3949

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

785

5146

1.81

36.42

3.5

2.4

u/l

53.8

56.5

1.46

724

4723

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

360

1812

2.18

36.07

2.2

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

403

2119

2.10

36.07

8.9

5.6

mmol/l

1.1

0.60

375

1960

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

149

5.17

35.90

2.1

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

257

4.07

35.60

3.7

u/ml

651.7

2344.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1300

9918

1.75

35.09

6.7

4.5

mmol/l

6.6

0.02

1237

9187

(3037467) Urinalysis macro (dipstick) panel - Urine

1524

12194

1.80

34.59

6.3

4.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

354

1803

2.15

34.30

2.1

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

281

1307

2.32

33.99

3.6

2.7

e9/l

70.5

69.7

0.14

216

989

(3027945) Reticulocytes/100 erythrocytes in Blood

348

1768

2.15

33.91

3.5

2.9

1.8

0.56

308

1576

(3004809) Band form neutrophils/100 leukocytes in Blood

245

4.05

33.70

3.6

1.9

1.4

0.43

197

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

9.66

33.32

1.7

1.4

u/ml

33.7

27.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

113

5.62

32.61

1.7

1.8

—

(3018418) pH of Serum or Plasma

736

4874

1.76

32.10

6.0

3.8

7.4

0.25

158

931

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

140

476

3.07

31.68

3.6

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

143

493

3.03

31.59

3.1

2.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

675

4376

1.78

31.58

3.5

3.0

ng/l

1554.7

1345.0

0.52

574

3683

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

3.83

31.47

1.9

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

112

339

3.43

30.67

4.2

3.4

59.2

56.5

1.13

112

339

(3026493) Urate [Moles/volume] in Serum or Plasma

648

4186

1.77

30.50

3.8

2.6

umol/l

3270.5

5033.7

0.62

568

3653

(3020630) Protein [Mass/volume] in Serum or Plasma

260

1223

2.28

30.49

4.9

2.8

g/l

65.7

66.5

0.82

238

1113

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

144

511

2.94

30.22

1.9

1.6

titre

203.3

90.6

0.97

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

4.21

30.12

1.9

1.6

—

(3009343) pH of Capillary blood

231

1042

2.36

29.85

5.9

3.9

7.4

0.16

114

(21494814) CD8 cells/100 lymphocytes in Specimen

7.63

29.75

2.0

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

565

3530

1.81

29.65

1.9

1.4

g/l

2.2

2.3

0.33

389

2153

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

225

1007

2.37

29.59

5.8

3.9

mmol/l

1.6

1.7

0.15

166

732

(3015171) Extractable nuclear Ab [Units/volume] in Serum

159

603

2.76

29.50

1.3

1.2

u/ml

2.2

0.8

0.32

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

232

1055

2.34

29.41

5.9

3.9

kpa

5.1

5.2

0.17

216

986

(3004588) Protein electrophoresis panel - Serum or Plasma

220

978

2.39

29.37

3.8

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

194

4.19

29.21

1.8

1.5

—

(3000494) Fungus identified in Specimen by Culture

345

1842

2.03

29.16

1.9

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

107

326

3.40

29.00

3.7

3.2

e9/l

4.5

3.9

1.34

107

326

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

984

7207

1.66

28.69

2.8

2.3

nmol/l

75.6

76.4

0.38

904

6501

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

8.87

28.08

2.1

2.0

—

(3021589) Normoblasts [#/volume] in Blood

1040

7769

1.64

27.73

16.9

8.9

e9/l

0.0

0.44

899

6307

(3035350) Ketones [Presence] in Urine by Test strip

1131

8629

1.63

27.67

4.9

3.5

estimate

0.0

0.50

242

1618

(3030467) Casts [#/volume] in Urine by Automated count

691

4650

1.71

27.59

4.1

3.0

e6/l

0.3

0.5

1.35

564

3461

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

658

4373

1.72

27.49

2.7

2.2

mg/l

3.2

2.9

1.99

555

3715

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

102

5.40

27.35

3.1

2.7

e9/l

0.2

0.43

(3011897) Casein IgE Ab [Units/volume] in Serum

14.04

27.09

1.4

1.0

u/ml

27.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

107

5.25

26.97

3.0

2.6

e6/l

591.0

465.4

0.94

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

583

3768

1.74

26.82

2.0

1.8

mg/l

1.2

0.08

459

2861

(3000850) Epithelial cells [#/volume] in Urine

553

3528

1.76

26.60

3.5

2.5

e6/l

5.3

6.6

1.73

502

3083

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

125

4.82

26.24

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

125

4.82

26.24

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

125

4.82

26.24

1.8

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

388

2240

1.89

25.87

2.0

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1124

8655

1.60

25.77

6.4

4.8

estimate

0.0

0.50

254

1650

(40758558) Short blood count panel - Blood

654

4404

1.69

25.71

11.9

6.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

291

1530

2.04

25.47

3.0

2.3

g/l

0.2

0.12

262

1436

(3009261) Glucose [Presence] in Urine by Test strip

1131

8744

1.60

25.33

5.0

3.5

estimate

0.0

0.80

245

1609

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

231

3.65

25.05

1.8

1.5

—

(3026782) Osmolality of Urine

520

3320

1.74

24.70

3.8

2.7

mosm/kgh2o

509.3

549.1

3.90

460

2825

(3018095) Leukocytes [#/volume] in Urine

845

6121

1.61

24.66

4.6

3.5

e6/l

63.3

100.3

0.98

632

4167

(3018677) aPTT in Platelet poor plasma by Coagulation assay

414

2477

1.83

24.52

2.4

2.3

29.6

0.01

402

2408

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

110

4.91

24.16

2.1

1.6

—

(3037756) Immunofixation for Serum or Plasma

300

3.23

23.66

2.4

1.6

—

(36304419) Bacteria [Presence] in Urine

664

4571

1.65

23.59

4.0

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

201

947

2.23

23.30

1.6

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

135

531

2.64

23.29

1.8

1.6

iu/ml

2.7

0.1

0.59

102

(40760888) Immunoglobulin light chains.free panel - Serum

314

3.15

23.20

5.3

4.0

—

(44806118)

191

3.81

23.20

2.0

1.6

—

(44790049)

191

3.81

23.20

2.0

1.6

—

(44790047)

191

3.81

23.20

2.0

1.6

—

(44790048)

191

3.81

23.20

2.0

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

269

1420

2.02

23.19

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

722

5098

1.62

23.05

4.3

3.1

e6/l

39.9

84.0

1.43

597

3863

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

115

419

2.84

22.99

5.1

3.9

ratio

6.5

1.8

0.62

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1046

8058

1.56

22.94

3.6

2.8

ug/l

154.5

109.1

1.92

966

7465

(3034860) Kappa light chains.free [Mass/volume] in Serum

116

429

2.80

22.55

5.2

3.9

mg/l

82.5

71.7

0.11

359

(3026008) Bacteria identified in Urine by Culture

738

5269

1.60

22.35

3.9

3.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

116

432

2.78

22.26

5.2

3.9

mg/l

44.2

84.0

0.62

361

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

112

413

2.80

21.89

2.1

2.2

mg/l

12.3

11.0

0.48

105

377

(3048689) Calprotectin [Mass/mass] in Stool

372

2225

1.81

21.85

3.3

2.4

ug/g

125.3

119.9

0.15

290

1750

(3008757) Leukocyte morphology finding [Identifier] in Blood

176

3.83

21.84

4.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

157

691

2.37

21.33

6.9

4.3

mmol/l

24.7

24.8

0.14

145

652

(3044640) Blood type and Crossmatch panel - Blood

767

5574

1.57

21.30

3.1

2.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

106

387

2.83

21.11

1.5

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

245

3.31

20.85

1.9

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

4.54

20.82

2.5

2.3

e6/l

671.3

671.7

0.00

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

37.57

20.78

1.1

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1973

17893

1.92

20.74

26.4

12.6

mg/l

21.0

22.7

1.81

1741

13892

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

101

363

2.87

20.71

1.5

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

7.52

20.38

1.2

1.1

u/ml

2.0

0.4

0.76

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

152

675

2.34

20.23

2.1

1.8

g/l

1.7

1.5

1.25

136

588

(3028433) Virus identified in Specimen by Culture

6.43

20.11

1.2

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

461

2995

1.68

20.03

1.9

1.7

nmol/l

1272.9

1177.7

1.27

351

2281

(40761535) Cells panel - Urine sediment

245

1317

1.97

19.95

4.9

3.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

242

3.26

19.90

1.6

g/l

0.5

0.8

2.53

180

(4062490)

142

4.02

19.89

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

174

3.70

19.85

1.3

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

780

5761

1.55

19.82

4.7

3.2

mmol/l

2.3

2.4

4.52

687

5078

(3024139) IgG subclass 3 [Mass/volume] in Serum

139

4.03

19.62

1.5

g/l

0.4

0.01

(3028192) IgG subclass 2 [Mass/volume] in Serum

139

4.03

19.62

1.5

g/l

2.2

3.0

1.82

(3027135) IgG subclass 1 [Mass/volume] in Serum

139

4.03

19.62

1.5

g/l

5.9

7.0

0.95

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

357

2.83

19.61

1.7

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

455

2961

1.67

19.60

1.3

1.2

iu/ml

31.2

31.8

0.04

143

914

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

313

2.95

19.59

1.6

1.2

u/ml

18.3

4.7

0.42

(3022313) Gas panel - Capillary blood

166

777

2.23

19.51

7.1

4.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

111

433

2.65

19.48

1.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

601

4210

1.59

19.16

3.1

2.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

368

2.77

19.08

1.6

1.3

u/ml

343.4

247.1

1.59

220

(3033658) Prothrombin time (PT) actual/Normal

609

4286

1.58

19.01

5.6

3.9

91.6

91.1

0.20

591

4171

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

412

2.65

18.74

1.5

1.2

u/ml

24.3

8.5

0.88

(3048929) Epstein Barr virus Ab [Presence] in Serum

146

659

2.30

18.71

1.5

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

105

407

2.66

18.66

1.5

1.2

u/ml

13.6

2.9

0.55

(3029937) Albumin [Presence] in Urine by Test strip

649

4657

1.56

18.52

5.7

3.7

estimate

0.0

1.08

237

1610

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

871

6664

1.51

18.41

5.3

3.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

110

440

2.58

18.36

1.5

1.2

u/ml

26.7

50.9

0.67

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

431

2812

1.66

18.25

1.3

1.2

u/ml

18.8

11.7

0.30

163

1091

(3017354) Segmented neutrophils/100 leukocytes in Blood

147

3.81

18.18

3.4

3.1

59.8

55.2

0.66

104

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

147

674

2.26

18.15

2.2

2.0

u/l

39.4

38.9

0.08

132

600

(3021447) Carbon dioxide [Partial pressure] in Venous blood

262

1486

1.87

18.09

5.7

4.2

kpa

5.8

0.23

255

1441

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

9.63

17.90

1.2

3.4

—

(3019060) Gas panel - Arterial blood

195

1004

2.03

17.90

5.4

4.6

—

(3003396) Base excess in Arterial blood by calculation

299

1775

1.79

17.78

8.1

7.2

mmol/l

1.3

1.1

0.57

228

1376

(3002032) Base excess in Venous blood by calculation

260

1479

1.86

17.78

5.8

4.2

mmol/l

1.9

0.10

216

1166

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

359

2.72

17.75

1.7

1.4

—

19.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

329

2.78

17.35

1.8

1.5

u/ml

120.6

123.2

0.06

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1044

8351

1.47

17.35

5.1

3.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

6.24

17.21

1.5

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

288

1709

1.79

17.12

4.4

3.1

—

(3020891) Body temperature

131

590

2.30

16.88

6.1

4.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

296

1779

1.77

16.84

8.3

7.2

kpa

5.0

5.1

0.46

279

1690

(3027801) Oxygen [Partial pressure] in Arterial blood

296

1780

1.76

16.80

8.3

7.2

kpa

12.3

12.5

0.26

277

1691

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

117

503

2.40

16.76

2.6

3.4

g/l

3.8

3.6

0.81

111

478

(3011397) Hemoglobin [Presence] in Urine by Test strip

566

4015

1.55

16.72

4.7

3.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

510

3535

1.57

16.68

1.7

pmol/l

85816052.2

25000429.6

0.78

423

2960

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

575

4108

1.54

16.39

1.3

u/ml

1.3

1.5

0.35

147

1068

(3016502) Oxygen saturation in Arterial blood

268

1578

1.79

16.33

8.6

7.7

95.5

95.7

0.16

253

1515

(3042111) Morphology [Interpretation] in Bone marrow Narrative

251

2.97

16.26

2.0

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

529

3737

1.55

15.79

1.7

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

182

960

1.98

15.58

8.2

6.6

mmol/l

24.6

24.5

0.06

171

887

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

471

3254

1.57

15.49

1.9

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

118

528

2.30

15.45

2.1

2.4

ug/l

176.4

462.1

1.97

107

494

(1616796) Gas panel - Central venous blood

356

2.59

15.40

4.4

3.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

139

668

2.15

15.30

2.4

1.8

—

(3025941) Bacteria identified in Stool by Culture

184

984

1.95

15.13

1.4

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

184

3.21

14.83

1.7

1.6

58.7

61.9

0.24

119

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

745

5711

1.46

14.75

4.9

3.1

u/l

32.3

31.7

0.14

700

5423

(4035726)

245

1448

1.78

14.69

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

411

2788

1.58

14.54

3.2

2.6

e6/l

1.0

1.4

0.86

260

1535

(3000991) Gas panel - Venous blood

232

1354

1.80

14.51

10.1

8.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.18

14.40

2.1

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

307

1948

1.67

14.22

8.9

6.8

mmol/l

104.0

104.5

1.07

297

1899

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.21

14.20

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.47

14.02

2.3

1.6

—

(3019225) pH of Specimen

266

1631

1.72

13.99

6.9

3.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

611

2.14

13.95

2.1

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.81

13.55

2.1

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.81

13.55

2.1

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.81

13.55

2.1

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

5.47

13.54

2.1

3.0

e6/l

235.7

168.0

0.36

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.30

13.38

2.0

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.30

13.38

2.0

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.30

13.38

2.0

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.30

13.38

2.0

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

216

1269

1.78

13.19

3.6

2.6

ml/min/173m2

61.5

68.1

1.54

495

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.34

13.13

2.3

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

174

959

1.88

13.07

1.9

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

849

6781

1.41

12.99

2.1

1.9

pmol/l

97.5

96.0

0.41

500

3479

(3007566) Smooth muscle Ab [Titer] in Serum

101

456

2.27

12.98

1.2

titre

38.3

87.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

240

1461

1.72

12.93

9.5

7.9

g/l

119.2

121.2

0.78

232

1401

(46235355) HIV 1 and 2 tests - Meaningful Use set

537

3945

1.48

12.93

2.2

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

294

1891

1.64

12.86

4.3

2.9

umol/l

8.2

7.9

0.08

258

1620

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.48

12.85

1.5

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.41

12.63

3.5

4.4

—

(3042631) Mycobacterium sp identified in Specimen

203

2.91

12.58

3.6

2.8

—

(3034770) Mitochondria Ab [Titer] in Serum

101

463

2.24

12.53

1.2

—

1131.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1564

13900

1.42

12.49

4.9

4.0

pmol/l

14.8

14.7

1.19

1426

12683

(3003181) Sodium [Moles/volume] in Urine

266

2.65

12.48

1.3

1.4

mmol/l

65.7

68.1

0.19

220

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

451

2.25

12.46

2.1

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

211

1253

1.76

12.41

5.2

3.9

ng/l

101.0

83.7

1.43

185

1093

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

351

2.42

12.39

1.5

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.50

12.37

1.9

1.5

—

(3012501) Base excess in Blood by calculation

371

2.37

12.28

4.9

4.0

mmol/l

2.2

2.5

0.56

245

(3014599) Egg white IgE Ab [Units/volume] in Serum

109

3.62

12.17

1.2

1.0

u/ml

8.8

0.5

1.88

(3024354) Oxygen [Partial pressure] in Venous blood

208

1239

1.75

12.10

6.0

3.6

kpa

4.8

4.6

0.50

202

1202

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

412

2.29

12.07

1.6

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

228

1397

1.70

11.98

7.9

7.1

mmol/l

1.5

1.4

1.14

219

1332

(3019550) Sodium [Moles/volume] in Serum or Plasma

1938

18017

1.60

11.93

26.5

14.4

mmol/l

139.4

139.7

5.46

1907

17513

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

554

2.10

11.85

4.1

2.6

g/l

3.5

3.7

0.72

404

(3021960) Folate [Moles/volume] in Serum or Plasma

515

3809

1.46

11.84

1.7

1.5

nmol/l

19.4

20.5

0.93

451

3245

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

555

2.09

11.80

4.1

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

555

2.09

11.80

4.1

2.6

g/l

7.5

0.02

427

(3023420) DNA double strand Ab [Units/volume] in Serum

167

3.04

11.78

1.9

1.4

iu/ml

35.8

19.7

—

(3013512) EKG study

611

4672

1.42

11.72

4.6

3.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1940

18065

1.59

11.56

26.7

14.5

mmol/l

4.0

0.76

1910

17525

(40767503) Oxygen content in Capillary blood by calculation

325

2.42

11.56

2.9

2.5

16.5

16.3

0.09

156

(3022145) Colonoscopy Study observation

278

1811

1.61

11.50

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

303

2.46

11.37

2.2

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

432

3110

1.48

11.35

4.5

3.5

ng/l

252.6

431.9

1.06

304

2315

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

100

3.64

11.35

2.9

2.7

32.2

40.7

1.42

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.15

11.26

3.6

2.3

—

(3019150) Specific gravity of Urine by Refractometry

512

3817

1.44

11.21

5.3

3.8

kg/l

1.0

0.09

561

(3037121) Protein [Mass/volume] in Urine

119

609

2.01

11.12

4.3

3.2

g/l

0.3

0.25

251

(3039162) Centromere protein B Ab [Units/volume] in Serum

195

2.81

11.10

1.7

1.3

u/ml

0.7

67.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

298

2.43

10.81

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

194

1171

1.72

10.76

2.5

2.4

au/ml

26.5

20.6

0.31

(3017704) Immunofixation for Urine

3.81

10.76

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

3.58

10.76

1.4

1.0

u/ml

19.7

1.3

1.02

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1334

11680

1.36

10.71

4.5

3.0

u/l

53.3

43.8

3.23

1257

10946

(21494890) Protein electrophoresis panel - 24 hour Urine

145

3.08

10.64

2.7

2.1

—

(3011436) Histone Ab [Units/volume] in Serum

7.54

10.56

1.2

1.1

u/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

110

3.40

10.56

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

101

3.50

10.45

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

101

3.50

10.45

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

242

1560

1.62

10.43

6.1

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

215

1346

1.66

10.40

6.9

3.4

mmol/l

1.2

1.36

189

1161

(3021788) Differential panel - Synovial fluid

285

2.43

10.40

1.8

1.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

102

3.47

10.30

1.5

1.1

u/ml

22.5

3.8

—

(3017732) Neutrophils [#/volume] in Blood

196

1202

1.69

10.25

3.9

2.7

e9/l

4.2

4.1

0.17

143

950

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

288

2.40

10.17

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

100

498

2.06

10.10

3.5

u/ml

0.3

0.4

0.14

278

(3023419) Bacteria identified in Sputum by Culture

194

2.72

10.08

5.2

2.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

207

2.65

9.94

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

177

1065

1.72

9.93

1.3

au/ml

37.1

39.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

3.51

9.90

1.2

u/ml

1.4

16.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

110

3.31

9.86

1.4

1.2

u/ml

75.3

72.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

524

2.01

9.82

3.6

2.7

g/l

3.2

0.12

415

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

193

2.68

9.63

1.2

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

514

2.01

9.62

4.4

2.7

g/l

10.2

10.1

0.05

442

(3000475) Leukocytes [#/volume] in Synovial fluid

366

2.20

9.61

1.9

1.7

e6/l

25936.8

14181.1

0.64

273

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

253

2.45

9.56

1.2

—

(4010399)

181

1108

1.69

9.54

1.5

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

421

2.11

9.49

3.2

2.7

g/l

0.0

1.09

390

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

477

2.04

9.40

3.3

2.8

g/l

1.2

0.03

422

(3008898) HLA-B27 [Presence]

119

649

1.88

9.27

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

203

2.60

9.25

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

839

6959

1.33

9.21

2.2

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1988

18786

1.56

9.19

27.4

14.5

umol/l

80.2

74.7

5.54

1988

18779

(3043409) Potassium [Moles/volume] in Arterial blood

455

2.04

9.12

5.0

3.9

mmol/l

3.8

3.9

0.71

423

(3026389) Candida sp identified in Specimen by Organism specific culture

241

2.44

9.07

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

365

2653

1.45

8.96

3.4

2.8

e6/l

4.0

2.7

1.11

212

1413

(40768797) Stomach Pathology biopsy report

319

2260

1.48

8.94

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

581

4578

1.36

8.92

3.8

3.3

mg/l

659.9

222.0

1.06

363

2867

(3042733) HLA Ab [Presence] in Serum

4.22

8.92

5.4

4.6

—

(3004616) Nuclear Ab [Presence] in Serum

179

2.66

8.79

1.5

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

286

1990

1.50

8.75

21.3

23.5

inr

1.3

0.26

265

(3003888) Timothy IgE Ab [Units/volume] in Serum

328

2.20

8.73

1.1

1.0

u/ml

12.0

5.2

1.51

169

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

265

2.34

8.67

1.3

1.4

u/l

29.4

24.4

0.50

218

(3041096) Erythrocytes [Presence] in Urine by Automated

600

4772

1.35

8.63

4.6

3.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

103

554

1.90

8.40

1.6

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

340

2.16

8.40

1.6

1.2

u/ml

44.5

53.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

327

2.18

8.39

2.0

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

394

2.07

8.37

3.5

3.1

mmol/l

24.4

24.8

0.38

341

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1374

12297

1.31

8.33

3.6

3.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

128

2.92

8.29

1.8

1.4

32.6

31.7

0.04

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

103

557

1.89

8.27

2.5

3.1

94.4

91.3

0.74

521

(3020682) Albumin/Creatinine [Ratio] in Urine

602

4822

1.34

8.19

4.6

4.0

mg/mmol

10.2

7.8

0.64

378

3018

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

108

3.09

8.13

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

635

5135

1.33

8.08

3.7

3.3

mmol/l

7.1

7.6

1.66

527

4347

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

158

976

1.67

8.06

10.2

9.1

1.4

1.3

0.61

152

969

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

505

1.92

8.04

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

237

2.35

7.99

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

100

543

1.88

7.94

5.0

3.7

mmol/l

1.4

0.14

535

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

369

2.07

7.89

1.1

u/ml

1.9

1.4

0.16

136

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1762

16398

1.36

7.76

5.8

4.7

mu/l

1.9

2.1

0.44

1628

15102

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1761

16393

1.36

7.70

21.0

11.7

ml/min/173m2

82.7

83.8

1.13

1529

13378

(4034850)

527

1.88

7.70

11.9

10.1

—

(3021901) Oxygen saturation in Capillary blood

273

2.23

7.69

3.0

2.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

306

2.16

7.67

4.0

3.4

u/ml

96.0

1255.5

0.79

288

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

155

968

1.65

7.59

10.6

9.2

0.8

0.7

0.88

149

962

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.37

7.58

2.1

7.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

191

1256

1.57

7.56

3.8

2.7

ng/l

181.7

196.5

0.20

173

1145

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

382

2.02

7.56

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

104

584

1.82

7.44

1.3

1.4

—

(36660697) Celiac disease serology panel - Serum

213

1441

1.53

7.43

1.2

—

(3045142) Bone marrow Pathology biopsy report

183

2.49

7.43

1.5

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.94

7.38

2.8

2.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

506

1.87

7.36

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

143

2.69

7.33

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

149

2.65

7.30

1.2

u/l

70.2

56.2

0.29

104

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

135

822

1.68

7.30

6.0

5.0

mmol/l

24.5

24.0

0.96

122

760

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

479

1.89

7.28

5.6

5.9

mg/l

1.6

1.5

0.55

445

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1986

18910

1.48

7.27

18.1

9.5

u/l

26.5

25.7

1.17

1940

18238

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

137

839

1.67

7.25

11.7

9.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

204

2.38

7.22

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

100

3.03

7.20

1.3

1.0

u/ml

1.6

0.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.20

7.12

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.20

7.12

1.3

1.7

—

(40768446) Kidney Pathology biopsy report

3.78

7.08

2.0

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

513

1.85

7.06

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

398

3055

1.37

7.03

4.2

2.9

mmol/l

2.4

0.06

357

2680

(3008401) Mugwort IgE Ab [Units/volume] in Serum

319

2.07

6.92

1.1

u/ml

2.9

1.0

0.88

128

(40761511) CBC panel - Blood by Automated count

1968

18737

1.44

6.89

22.9

11.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

554

1.80

6.89

1.6

1.5

u/l

12.7

9.6

1.23

448

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

195

1320

1.52

6.79

2.2

2.3

ug/l

5.8

7.3

0.88

167

1150

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

393

1.94

6.67

3.4

2.8

g/l

0.0

0.00

364

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

228

1600

1.47

6.67

3.1

2.2

u/l

35.7

68.6

0.56

195

1362

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

257

2.17

6.65

1.2

1.1

—

(44813793)

105

2.88

6.63

1.1

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

394

1.94

6.63

3.4

2.8

g/l

0.0

0.00

364

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

332

2.02

6.59

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

332

2.02

6.59

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

459

1.86

6.59

1.4

ug/g

285.4

293.2

0.11

247

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.58

6.59

6.3

4.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.12

6.59

1.6

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

152

2.53

6.53

3.8

2.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

116

700

1.69

6.51

4.2

2.8

0.7

1.40

108

675

(3047181) Lactate [Moles/volume] in Blood

498

1.82

6.48

6.8

5.8

mmol/l

1.2

1.3

0.09

430

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.08

6.47

1.6

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

135

2.62

6.47

2.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1681

15662

1.30

6.46

6.4

5.3

mmol/mol

39.6

39.3

0.64

1544

14530

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.14

6.43

3.0

1.7

—

(3047189) Immunofixation for 24 hour Urine

3.26

6.28

3.2

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.85

6.26

1.6

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

264

2.11

6.24

5.2

umol/l

374.1

369.7

0.08

230

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.43

6.23

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

212

2.24

6.21

1.5

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

439

1.85

6.21

3.4

2.7

g/l

37.2

37.5

0.19

380

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

132

2.60

6.21

1.6

1.2

u/ml

0.5

0.7

0.21

(3052592) Norovirus Ag [Presence] in Stool

4.69

6.21

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

347

1.96

6.19

1.7

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

299

2.03

6.17

3.5

2.9

—

(3024471) HLA-A [Type]

3.53

6.16

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

213

2.23

6.15

1.5

1.4

—

(3036489) Thrombin time

110

666

1.69

6.11

2.4

2.7

21.2

21.4

0.22

584

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.81

6.11

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

214

2.22

6.08

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

117

2.67

5.99

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

3.00

5.96

1.7

1.5

umol/l

14.0

23.0

1.43

(3010726) Horse dander IgE Ab [Units/volume] in Serum

304

2.00

5.91

1.1

u/ml

5.6

1.2

1.42

(21494434) Karyotype in Bone marrow

136

2.52

5.87

1.3

1.2

—

(3000492) Spirometry study

226

1623

1.44

5.87

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

211

2.21

5.86

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

212

2.19

5.80

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

212

2.19

5.80

1.5

1.4

—

(3044941) Cell count panel - Synovial fluid

246

2.10

5.74

1.8

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

222

1599

1.43

5.67

5.0

4.0

ug/l

18.4

19.9

0.07

183

1291

(3052851) Hemolysis interference index of Serum or Plasma

512

1.75

5.67

3.3

3.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

157

2.38

5.65

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

255

2.06

5.61

1.1

1.0

u/ml

12.6

2.1

1.94

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

499

1.75

5.59

1.2

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.30

5.58

2.5

3.4

—

47.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.30

5.58

3.4

2.5

mg/l

9.5

9.8

0.08

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.82

5.57

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

116

2.61

5.55

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

3.64

5.48

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

135

2.47

5.46

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

118

2.56

5.38

1.1

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

102

629

1.65

5.33

7.2

4.8

1.9

1.6

0.74

584

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

264

1982

1.38

5.31

11.0

6.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

137

2.43

5.30

1.4

1.3

e6/l

176107.7

91823.3

0.20

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

11.29

5.29

1.8

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.02

5.26

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

176

2.24

5.20

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.14

5.19

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.14

5.19

1.6

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.28

5.04

7.0

3.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

233

2.04

4.97

1.1

u/ml

7.1

4.7

0.48

(40768441) Liver Pathology biopsy report

123

2.46

4.96

1.9

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

247

2.01

4.95

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

160

1113

1.47

4.93

3.0

3.3

pmol/l

4.4

4.6

0.62

143

989

(3023183) Ammonium ion [Moles/volume] in Plasma

325

1.87

4.92

3.1

3.2

umol/l

30.4

36.4

1.44

280

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

125

826

1.54

4.92

10.8

9.6

mmol/l

24.5

24.3

0.21

115

771

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.35

4.88

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

279

2144

1.34

4.84

1.8

1.7

1.5

1.4

0.42

246

1889

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.08

4.79

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.02

4.78

1.0

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.89

4.76

2.3

1.7

umol/l

15.9

39.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.66

4.65

1.1

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.70

4.64

1.4

33.2

22.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

146

2.28

4.64

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.15

4.62

1.3

1.1

73.5

92.4

0.99

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.15

4.62

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.35

4.60

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.69

4.58

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.82

4.55

1.7

2.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.03

4.52

1.8

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.07

4.51

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.07

4.51

3.3

2.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

265

2046

1.34

4.45

4.8

4.2

31.7

32.5

0.50

198

1404

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

510

1.65

4.45

1.3

—

(3045414) Leukocytes [Presence] in Urine

119

801

1.51

4.34

2.0

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.22

4.33

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

8.92

4.28

7.0

5.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.57

4.22

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

388

1.72

4.18

1.7

1.6

e6/l

56.0

790.1

1.47

321

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

388

1.72

4.18

1.7

1.6

e6/l

35.2

38.5

0.05

307

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.54

4.13

1.7

1.5

u/l

3.4

9.3

1.04

(3024932) HLA-DR beta [Type]

3.00

4.12

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.81

4.12

3.3

4.1

mg/l

7.6

8.6

0.36

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.81

4.12

1.6

1.3

4.2

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.72

4.09

1.3

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.21

4.05

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

430

1.67

4.05

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.45

3.98

1.2

—

(3036603) Volume of Urine

105

2.40

3.98

1.8

1.5

1969.4

1950.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

124

2.27

3.97

1.4

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.03

3.96

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.65

3.92

1.9

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

144

1031

1.42

3.87

1.5

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

352

1.72

3.86

2.7

2.3

g/l

129.0

130.6

0.19

260

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

7.30

3.86

1.0

—

(40768795) Lymph node Pathology biopsy report

159

2.09

3.83

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

146

2.14

3.81

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

114

2.30

3.78

1.3

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

251

1.85

3.76

1.8

2.6

u/ml

3.9

22.4

0.60

230

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

12.03

3.76

1.5

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

497

1.59

3.67

1.1

u/ml

2.0

4.1

—

(3019174) dRVVT (LA screen)

5.64

3.66

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.12

3.65

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

2.55

3.63

3.8

2.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

475

1.60

3.62

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1596

15115

1.20

3.59

28.1

15.6

13.9

13.6

8.83

1580

14759

(3044889) 12 lead EKG panel

1271

11806

1.18

3.57

4.5

3.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.95

3.57

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

149

1090

1.39

3.56

2.0

2.1

nmol/l

11.7

12.1

0.21

134

949

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.51

3.54

1.1

1.2

—

(4015189)

3.06

3.53

3.4

2.1

—

(3030313) Adrenal Ab [Titer] in Serum

5.31

3.51

1.6

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

5.31

3.51

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.55

3.46

2.8

2.2

umol/l

2.0

1.9

0.21

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.99

3.41

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.99

3.41

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

260

1.79

3.40

1.3

1.2

u/l

47.5

43.4

0.05

217

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

100

686

1.48

3.39

1.4

1.3

miu/ml

225.5

234.1

0.07

337

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.84

3.35

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.63

3.30

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

2060

20100

1.35

3.26

35.9

18.7

e9/l

7.0

6.7

3.61

2026

19505

(3007461) Platelets [#/volume] in Blood

2058

20081

1.34

3.22

36.0

18.7

e9/l

255.9

253.4

0.84

2029

19541

(3024731) MCV [Entitic volume]

2059

20094

1.34

3.20

35.7

18.6

91.0

90.6

3.28

2041

19806

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

6.38

3.18

3.3

2.4

mg/l

2.6

3.6

—

(3026361) Erythrocytes [#/volume] in Blood

2059

20097

1.34

3.17

35.9

18.7

e12/l

4.4

4.5

15.25

2027

19502

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

222

1.82

3.15

1.1

1.0

u/ml

1.6

0.0

0.77

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.51

3.11

7.4

3.6

—

(3035941) MCH [Entitic mass]

2058

20095

1.33

3.08

35.7

18.6

30.2

0.28

2041

19805

(3000963) Hemoglobin [Mass/volume] in Blood

2059

20108

1.33

3.06

36.1

18.8

g/l

132.0

134.9

15.33

2042

19815

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.25

3.06

1.3

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

7.52

3.05

1.2

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.52

3.05

5.8

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

153

1.97

3.05

7.7

3.4

—

(3045424) Erythrocytes [Presence] in Urine

292

1.69

3.05

1.7

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.51

3.04

1.7

2.1

umol/l

117.6

130.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

172

1324

1.32

3.01

1.3

1.2

iu/ml

97.7

146.9

0.93

493

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

154

1.96

3.00

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.30

2.99

1.2

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

10.02

2.98

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.55

2.95

5.1

2.3

ug/l

19.4

17.0

0.24

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.34

2.90

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.10

2.88

1.2

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1748

16797

1.19

2.87

5.1

4.2

mmol/l

5.9

1.26

1593

15337

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

1.96

2.80

1.2

1.3

—

(4268621)

180

1.85

2.78

2.1

2.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.92

2.77

1.1

1.3

—

(3019977) pH of Arterial blood

2.27

2.77

2.5

3.1

7.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.01

2.70

4.3

4.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

4.22

2.68

1.3

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1707

16400

1.18

2.67

4.2

3.7

mmol/l

1.3

3.26

1565

15086

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.06

2.67

2.9

3.3

103.8

95.7

0.47

106

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.34

2.65

2.6

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

135

1025

1.34

2.63

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.47

2.62

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

648

1.42

2.61

1.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

2.56

1.4

1.1

—

(3006270) Folate [Moles/volume] in Blood

128

1.96

2.55

1.2

1.1

nmol/l

278.5

390.4

2.66

113

(3023323) Follitropin [Units/volume] in Serum or Plasma

119

897

1.35

2.45

1.5

1.4

iu/l

25.5

25.2

0.03

105

761

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

294

2478

1.21

2.44

2.3

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

145

1.87

2.42

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.95

2.41

1.9

—

(3004451) EKG impression Narrative

2.30

2.41

1.2

—

(3048879) Bone marrow aspiration report

2.76

2.37

1.5

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.26

2.37

2.2

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.26

2.37

2.8

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

139

1.88

2.36

3.0

3.4

mu/l

25.9

23.3

0.17

134

(3013293) Extractable nuclear Ab [Presence] in Serum

3.65

2.36

2.6

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

199

1.72

2.32

2.8

2.4

mg/l

23.8

23.5

0.01

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

108

810

1.35

2.31

2.5

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

247

2058

1.23

2.31

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

105

2.01

2.31

4.0

3.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

735

1.36

2.26

1.9

1.6

mu/l

370.6

305.8

0.72

662

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

573

1.41

2.26

4.4

3.3

u/ml

6020.5

869.4

0.47

486

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

239

1.64

2.26

1.4

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.90

2.25

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

295

1.57

2.23

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

296

1.57

2.20

1.3

1.1

—

(4306422)

257

1.61

2.18

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

2.51

2.18

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

265

1.60

2.18

1.3

1.2

u/ml

3.1

5.5

0.82

115

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

117

897

1.32

2.18

2.8

2.2

u/l

1389.9

4684.0

2.37

359

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.29

2.15

1.5

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.01

2.14

4.6

7.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.11

2.12

1.2

u/l

37.1

15.2

1.16

(3010838) Calcium [Moles/time] in 24 hour Urine

2.05

2.11

1.4

1.7

—

9.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.57

2.09

1.1

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.21

2.09

2.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.21

2.09

2.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.21

2.09

2.1

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.01

2.07

1.2

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.08

2.07

1.2

u/l

121.2

74.4

1.19

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1770

17154

1.16

2.05

4.6

4.1

mmol/l

4.6

4.7

2.30

1642

15954

(3042517) Benzodiazepines panel - Urine

3.51

2.05

3.7

2.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.18

2.04

1.1

1.2

iu/ml

142.4

213.9

0.74

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.51

2.01

2.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.82

2.00

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.82

2.00

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.82

2.00

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.82

2.00

1.7

2.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.82

2.00

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.15

1.98

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

134

1.80

1.95

1.0

mg/l

268.7

241.5

0.21

116

(3013139) Helicobacter pylori Ag [Presence] in Stool

140

1118

1.27

1.94

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.82

1.94

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.82

1.94

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.82

1.94

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.76

1.93

1.0

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.73

1.93

2.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

158

1.72

1.89

1.3

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

1.76

1.89

1.2

mg/l

43.5

39.9

0.12

118

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.09

1.86

1.3

1.7

—

1130710.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

563

0.65

1.85

1.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1128

0.75

1.84

1.2

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1795

17451

1.15

1.84

5.0

4.5

mmol/l

2.7

2.8

1.61

1656

16121

(3051611) Lipemic interference index of Serum or Plasma

175

1.67

1.83

3.7

3.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1754

17028

1.14

1.82

4.6

4.0

mmol/l

1.4

1.5

4.38

1616

15747

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.17

1.82

8.6

4.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

313

2731

1.17

1.80

2.4

2.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

279

1.52

1.79

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

217

1.58

1.74

1.1

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

132

1.75

1.73

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

178

1.64

1.73

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.67

1.72

1.6

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.92

1.72

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

348

1.45

1.72

2.0

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

—

(4024509)

156

1.67

1.69

1.9

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

491

4452

1.13

1.64

1.7

1.6

mmol/l

1.4

1.11

405

3757

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.93

1.64

1.1

98.5

91.6

—

(3004775) Volume in Urine collected for unspecified duration

127

1.74

1.64

3.3

2.3

636.9

601.9

0.16

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

498

0.66

1.62

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

645

1.31

1.62

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.07

1.59

1.1

83.4

90.8

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.07

1.59

1.1

108.7

112.8

0.14

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

448

1.37

1.57

2.6

1.9

iu/l

8.0

4.7

0.80

152

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

374

1.40

1.52

3.5

2.4

ug/min

74.5

99.2

0.26

232

(3024869) Neuronal Ab [Presence] in Serum

2.60

1.51

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

449

4071

1.13

1.51

5.2

4.9

ug/l

2.6

2.9

0.21

393

3629

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.86

1.50

3.3

5.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.07

1.49

3.0

2.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.44

1.48

1.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

109

1.75

1.46

1.1

1.2

ratio

1.1

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

156

1.61

1.43

1.7

1.3

e6/l

20589.7

102566.1

0.92

(21494755) Public health laboratory ask at order entry panel

149

1773

0.83

1.43

1.4

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

188

1.55

1.43

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

188

1.55

1.43

1.6

1.4

g/l

31.9

32.7

0.11

166

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.31

1.43

1.6

1.1

47.3

57.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

110

1.73

1.43

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

141

1.64

1.41

2.1

1.4

promille

0.8

1.3

1.13

110

(3000012) Reticulocyte production index

1.82

1.41

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1.67

1.40

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1.67

1.40

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

126

1.67

1.40

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

296

1.43

1.40

1.2

1.1

iu/ml

14.4

1757.1

—

(3003694) ABO and Rh group [Type] in Blood

572

5286

1.11

1.37

1.6

1.5

—

(40758292) HTLV I+II Ab panel - Serum

2.61

1.36

1.3

—

(3023410) Appearance of Cerebral spinal fluid

183

1.54

1.34

2.4

1.9

—

(4146454)

167

1.56

1.34

2.3

2.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

274

1.43

1.33

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

102

1250

0.81

1.33

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

266

1.44

1.32

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

260

2295

1.15

1.32

1.9

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

258

1.44

1.31

1.2

1.1

131.5

117.2

1.38

235

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.78

1.28

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.78

1.28

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.09

1.27

1.4

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.09

1.27

1.9

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.09

1.27

1.9

2.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.09

1.27

2.8

5.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.94

1.27

1.1

78.3

91.4

—

(40757373) Influenza virus identified in Isolate

2.29

1.27

2.3

1.8

—

(3020491) Glucose [Moles/volume] in Blood

130

1.62

1.26

4.0

1.6

mmol/l

5.8

6.7

0.80

(3049717) Cytology report of Urine Cyto stain

546

1.29

1.26

2.0

2.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

107

1.69

1.25

2.6

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

131

1.61

1.23

1.0

1.1

—

(4211845)

1.71

1.17

3.2

2.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

166

1.51

1.15

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

139

1623

0.85

1.12

1.5

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.90

1.12

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.00

1.12

1.7

1.4

ug/l

8.8

9.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

406

1.31

1.11

6.2

4.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.97

1.11

1.1

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.38

1.09

4.4

9.1

mmol/l

6.2

6.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.38

1.09

1.2

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.38

1.09

1.0

—

(3002256) Pathology report gross observation

245

2191

1.13

1.06

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.71

1.05

1.4

1.1

miu/ml

1628.4

1529.0

0.09

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.80

1.04

1.2

—

(44806071)

2.28

1.03

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

342

1.32

1.01

3.8

2.3

nmol/l

1.1

0.8

1.11

289

(3012441) Differential panel - Pleural fluid

147

1.50

1.00

1.7

1.4

—

(4027681)

115

1.57

0.99

1.4

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.18

0.98

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.95

0.97

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.80

0.96

2.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

513

0.76

0.96

1.4

1.5

—

(3024263) Appearance of Synovial fluid

1.69

0.95

1.6

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

117

0.51

0.94

1.2

1.5

mmol/l

5.2

5.8

—

112

(3000330) Specific gravity of Urine by Test strip

102

863

1.19

0.94

5.0

3.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

522

0.76

0.94

1.4

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.23

0.93

1.2

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.23

0.93

1.0

—

(3005033) Fetal Nuchal fold Thickness US

509

0.76

0.92

1.4

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

313

1.32

0.92

1.4

ug/l

6.2

4.5

0.28

289

(3011288) Drugs identified in Urine by Screen method

600

1.22

0.91

3.1

3.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

353

3255

1.10

0.91

4.2

21.9

21.4

0.21

180

1534

(3006462) Nitrate [Presence] in Urine

1.63

0.91

3.5

2.9

—

(3015183) Erythrocyte sedimentation rate

102

1.57

0.90

1.4

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.75

0.90

1.8

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

212

1.37

0.86

1.2

1.3

nmol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.59

0.84

1.9

2.2

umol/l

65.1

52.3

—

(3005570) Glucose [Moles/volume] in Urine

196

1.38

0.84

1.7

2.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

297

0.70

0.84

1.3

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

129

1.48

0.83

1.0

iu/ml

11.1

13.0

—

(3022689) Creatine [Moles/volume] in Urine

1.74

0.82

2.4

1.6

—

(3045788) Cell count panel - Pleural fluid

146

1.44

0.82

1.7

1.3

—

(3008295) Osmolality of Serum or Plasma

180

1.39

0.82

1.3

1.4

mosm/kgh2o

279.4

280.9

0.15

136

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

293

1.30

0.81

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

225

0.66

0.81

1.3

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

276

1.31

0.80

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.79

0.0

6.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.82

0.79

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

349

3245

1.09

0.77

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.09

0.74

1.6

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.84

0.73

1.7

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.84

0.73

4.9

5.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

807

0.84

0.73

1.6

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

600

0.81

0.72

1.4

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.00

0.72

1.6

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.93

0.70

1.6

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

118

1.44

0.69

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.67

0.68

4.9

6.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

102

1.47

0.67

1.1

1.0

ng/l

729.7

702.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

103

1.46

0.65

1.1

1.0

ng/l

25.6

48.2

—

(3027008) Opiates [Presence] in Urine

101

887

1.15

0.64

2.4

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

386

1.22

0.64

2.4

3.1

—

(3026470) Cobalt [Mass/volume] in Blood

1.48

0.64

1.7

2.1

ug/l

3.1

2.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

673

1.16

0.63

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

711

1.16

0.62

2.4

1.7

mg/l

4.0

3.2

0.44

501

(3000764) Benzodiazepines [Presence] in Urine

100

880

1.14

0.62

2.5

2.3

—

(3028300) Cannabinoids [Presence] in Urine

101

890

1.14

0.62

2.5

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.67

0.61

1.2

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

262

1.26

0.61

1.1

1.0

u/ml

1.5

2.7

1.32

122

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

8.0

—

(3016879) Cocaine [Presence] in Urine

819

1.14

0.58

2.6

2.3

—

(4198724)

1.46

0.58

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

132

1.37

0.57

1.6

2.4

u/field

1.3

2.4

0.81

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.56

1.5

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

430

1.19

0.56

2.3

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

311

1.23

0.55

3.5

3.1

nmol/l

0.8

0.00

241

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

302

1.23

0.55

1.5

nmol/l

0.2

0.4

1.83

241

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.62

0.55

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1698

16749

1.06

0.54

23.7

13.8

39.3

39.7

1.28

1182

12414

(40768793) Breast Pathology biopsy report

432

1.18

0.53

1.3

—

(3027944) Amphetamines [Presence] in Urine

876

1.12

0.51

2.5

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

127

1.34

0.49

1.9

2.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

128

1.33

0.47

2.5

1.5

g/l

1.0

0.11

128

(3020650) Glucose [Presence] in Urine

1.49

0.47

1.0

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

252

2368

1.07

0.47

3.3

3.0

ug/l

0.8

0.09

180

1523

(3029075) Extractable nuclear Ab panel - Serum

1.46

0.46

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

155

1.29

0.46

1.9

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

111

1.35

0.46

1.3

1.1

u/l

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

631

0.87

0.45

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

352

0.82

0.45

2.1

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

630

0.87

0.44

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

630

0.87

0.44

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

1.35

0.43

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

627

0.87

0.42

1.5

1.4

—

(3034426) Prothrombin time (PT)

1.40

0.42

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.41

0.0

4.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.47

0.40

1.2

1.6

nmol/l

3.2

4.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

104

0.67

0.39

2.1

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

696

0.89

0.39

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

178

1.24

0.38

4.6

4.9

u/ml

60.7

95.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

694

1.11

0.38

2.4

2.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.35

0.37

2.2

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

115

0.69

0.37

1.0

1.3

nmol/l

33.9

29.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

272

1.18

0.36

1.3

1.2

u/ml

2.2

4.2

0.83

(3023511) Choriogonadotropin [Units/volume] in Urine

479

1.13

0.35

1.3

—

(3024928) Oxygen saturation in Venous blood

349

1.15

0.34

3.4

3.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

155

0.77

0.33

1.3

1.6

—

(3017569) Oxygen content in Arterial blood

1.35

0.32

2.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

418

1.13

0.31

1.3

1.6

nmol/l

44.1

40.7

0.44

400

(3035880) pH of Pleural fluid

1.31

0.30

1.4

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

212

2024

1.05

0.28

1.7

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

681

1.09

0.27

1.6

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

322

0.87

0.27

1.6

—

(3045716) Anion gap in Serum or Plasma

1.30

0.26

3.4

1.8

mmol/l

8.6

10.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.20

0.25

1.8

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

158

0.82

0.23

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

5.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

136

1297

1.05

0.21

2.1

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

387

0.90

0.20

4.6

3.3

mg/l

20.8

25.5

0.57

242

(1761868) Lipid panel - Serum or Plasma

635

6236

1.03

0.20

2.9

2.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

137

1.17

0.18

1.5

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

147

1.16

0.18

1.5

1.3

mmol/l

7.0

6.7

0.17

137

(3034274) Bile acid [Moles/volume] in Serum --fasting

291

1.10

0.17

2.0

2.5

umol/l

4.1

5.8

1.18

206

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.11

0.17

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

1.17

0.15

1.5

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.14

0.15

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.11

0.15

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

169

1639

1.03

0.14

2.2

2.0

—

(3011648) Oxygen content in Venous blood

141

1.14

0.14

3.8

4.3

11.2

11.1

0.01

141

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.82

0.13

1.3

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

170

1.12

0.13

1.1

1.4

mmol/l

8.4

11.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

180

1.11

0.13

4.4

2.5

—

(3022621) pH of Urine by Test strip

115

1188

0.97

0.11

2.7

2.8

—

(1002224) Polysomnography panel

682

1.04

0.10

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

193

1.09

0.10

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

106

1.13

0.09

6.7

7.4

—

(40768800) Prostate Pathology biopsy report

262

1.07

0.09

1.0

1.2

—

(4281824)

196

0.92

0.09

1.2

1.1

—

(4094501)

410

0.95

0.08

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

133

0.90

0.07

4.6

2.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.84

0.07

2.3

1.8

nmol/l

138.3

154.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

104

1016

1.02

0.07

1.8

1.7

—

(3003338) MCHC [Mass/volume]

1547

15510

0.99

0.06

29.7

16.2

g/l

331.7

332.5

2.64

1533

15387

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

119

1.09

0.06

10.8

11.1

mmol/l

0.7

0.6

0.26

109

(3006653) Thiamine [Moles/volume] in Blood

1.11

0.05

1.4

1.3

nmol/l

139.8

140.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

636

1.02

0.04

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

0.92

0.04

1.6

1.4

—

(3025130) Human papilloma virus identified in Specimen

272

1.03

0.02

1.4

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

127

1.02

0.00

1.6

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.88

0.00

1.2

35.2

59.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

382.6

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.0

—

71.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.85

0.00

3.4

1.3

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.6

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.0

—

36.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.00

0.00

1.4

3.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.00

0.00

1.0

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

0.95

0.00

1.3

13.8

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.94

0.00

3.1

2.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.8

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dermatitis due to substances taken internally

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Dermatitis due to substances taken internally (L12_INTERNALSUBSTANCEDERM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints